Sanofi: Colitis, Ulcerative trials
The registry lists 12 Colitis, Ulcerative studies with Sanofi as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 8Phase 3 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 SubstratesNot yet recruitingNCT07923383Phase 1
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruitingNCT07185009Phase 3
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruitingNCT07184996Phase 3
- A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS)TerminatedNCT07222189Phase 2
- A Study to Investigate the Efficacy and Safety of Brivekimig in Adult Participants With Ulcerative ColitisActive, not recruitingNCT06975722Phase 2
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisTerminatedNCT06867094Phase 2
- A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))Active, not recruitingNCT05731128Phase 2
- Dose-finding Study of SAR443122 in Adult Participants With Ulcerative ColitisActive, not recruitingNCT05588843Phase 2
- A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT03849599Phase 1
- Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)TerminatedNCT01861249Phase 2
- Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative ColitisTerminatedNCT01659138Phase 2
- Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety StudyCompletedNCT00232258Phase 2